0067-2037 NDC - EXCEDRIN ()

Drug Information

  • Product NDC: 0067-2037
  • Proprietary Name: EXCEDRIN
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Product Type:
FDA Application Number: NDA020802
Marketing Category: NDA
Start Marketing Date:2/15/2010
End Marketing Date:10/31/2014

Package Information

No. Package Code Package Description Billing Unit
10067-2037-022 TABLET, FILM COATED in 1 PACKET (0067-2037-02)
20067-2037-061 BOTTLE in 1 CARTON (0067-2037-06) / 6 TABLET, FILM COATED in 1 BOTTLE
30067-2037-101 BOTTLE in 1 CARTON (0067-2037-10) / 10 TABLET, FILM COATED in 1 BOTTLE
40067-2037-331 BOTTLE in 1 CARTON (0067-2037-33) / 300 TABLET, FILM COATED in 1 BOTTLE
50067-2037-501 BOTTLE in 1 CARTON (0067-2037-50) / 50 TABLET, FILM COATED in 1 BOTTLEEA
60067-2037-771 BOTTLE in 1 CARTON (0067-2037-77) / 250 TABLET, FILM COATED in 1 BOTTLEEA
70067-2037-831 BOTTLE in 1 CARTON (0067-2037-83) / 125 TABLET, FILM COATED in 1 BOTTLEEA
80067-2037-84125 TABLET, FILM COATED in 1 BOTTLE (0067-2037-84)
90067-2037-911 BOTTLE in 1 CARTON (0067-2037-91) / 100 TABLET, FILM COATED in 1 BOTTLEEA

NDC Record

Field Name Field Value Definition
PRODUCT NDC0067-2037The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEEXCEDRINThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXMIGRAINEA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
START MARKETING DATE2/15/2010This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE10/31/2014This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMENDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERNDA020802This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 5/9/2025

Previous Code
Next Code